Association of mitotic checkpoint regulator MAD2L1 with fibrosis progression in chronic hepatitis C patients - 28/05/22
Doi : 10.1016/j.clinre.2022.101860
Saira S. Khalid a, ⁎ 
, Ayman A. Abdo a, b, Waleed Al-hamoudi b, Khalid Alswat a, b
, Ayman A. Abdo a, b, Waleed Al-hamoudi b, Khalid Alswat a, b a Liver Disease Research Centre, Department of Medicine, College of Medicine, King Saud University, PO Box 2925 (59), Riyadh 11461, Saudi Arabia
b Gastroenterology Section, King Saud University Medical City, Riyadh, Saudi Arabia
⁎Corresponding author.
Highlights |
• | Differential miRNAs expression can help in investigating disrupted target proteins. |
• | Overexpression of p27 and MAD2L1 proteins in hepatitis C patients. |
• | Significant association of MAD2L1 overexpression with fibrosis progression. |
Keywords : Hepatitis C virus, Chronic hepatitis C, microRNAs, Cell cycle proteins, Cell cycle inhibitors, Mitosis regulator
Plan
© 2022
Elsevier Masson SAS. Tous droits réservés.
Vol 46 - N° 4
Article 101860- avril 2022 Retour au numéro
Article précédent
- Severe pruritis during pregnancy: More than just intrahepatic cholestasis of pregnancy?
- Ayushi Jain, Robert B Kirkpatrick, Lindsay A Sobotka
- Liver hypodense infectious lesions: Is it only bacteria, parasites or fungi?
- E. Hoornaert, J.C. Yombi, L. Coubeau, P. Baldin, G. Dahlqvist, H. Yildiz
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?